PYRIDOPYRIMIDINONES FOR THE TREATMENT OF CANCER DISEASES
The invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X and X' have the designations cited in patent claim 1. Said compounds are inhibitors of tyrosine kinases, especially TIE-2, and Raf kinases, and can, inter alia, be used for the treatment of tumors.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | RAUTENBERG, WILFRIED JONCZYK, ALFRED SOLER RIERA, MARTA MITJANS, FRANCESC ROSELL-VIVES, ELISABET ACKERMANN, KARL-AUGUST ADAN, JAUME HOELZEMANN, GUENTER STAEHLE, WOLFGANG CRASSIER, HELENE |
| description | The invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X and X' have the designations cited in patent claim 1. Said compounds are inhibitors of tyrosine kinases, especially TIE-2, and Raf kinases, and can, inter alia, be used for the treatment of tumors. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP1682548A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP1682548A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP1682548A13</originalsourceid><addsrcrecordid>eNrjZLAIiAzydPEHkb6eLp5-_n6uwQpu_kEKIR6uCiFBro4hvq5-IQr-bgrOjn7OrkEKLp7Bro7BrsE8DKxpiTnFqbxQmptBwc01xNlDN7UgPz61uCAxOTUvtSTeNcDQzMLI1MTC0dCYCCUAPAMoWg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRIDOPYRIMIDINONES FOR THE TREATMENT OF CANCER DISEASES</title><source>esp@cenet</source><creator>RAUTENBERG, WILFRIED ; JONCZYK, ALFRED ; SOLER RIERA, MARTA ; MITJANS, FRANCESC ; ROSELL-VIVES, ELISABET ; ACKERMANN, KARL-AUGUST ; ADAN, JAUME ; HOELZEMANN, GUENTER ; STAEHLE, WOLFGANG ; CRASSIER, HELENE</creator><creatorcontrib>RAUTENBERG, WILFRIED ; JONCZYK, ALFRED ; SOLER RIERA, MARTA ; MITJANS, FRANCESC ; ROSELL-VIVES, ELISABET ; ACKERMANN, KARL-AUGUST ; ADAN, JAUME ; HOELZEMANN, GUENTER ; STAEHLE, WOLFGANG ; CRASSIER, HELENE</creatorcontrib><description>The invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X and X' have the designations cited in patent claim 1. Said compounds are inhibitors of tyrosine kinases, especially TIE-2, and Raf kinases, and can, inter alia, be used for the treatment of tumors.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060726&DB=EPODOC&CC=EP&NR=1682548A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060726&DB=EPODOC&CC=EP&NR=1682548A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RAUTENBERG, WILFRIED</creatorcontrib><creatorcontrib>JONCZYK, ALFRED</creatorcontrib><creatorcontrib>SOLER RIERA, MARTA</creatorcontrib><creatorcontrib>MITJANS, FRANCESC</creatorcontrib><creatorcontrib>ROSELL-VIVES, ELISABET</creatorcontrib><creatorcontrib>ACKERMANN, KARL-AUGUST</creatorcontrib><creatorcontrib>ADAN, JAUME</creatorcontrib><creatorcontrib>HOELZEMANN, GUENTER</creatorcontrib><creatorcontrib>STAEHLE, WOLFGANG</creatorcontrib><creatorcontrib>CRASSIER, HELENE</creatorcontrib><title>PYRIDOPYRIMIDINONES FOR THE TREATMENT OF CANCER DISEASES</title><description>The invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X and X' have the designations cited in patent claim 1. Said compounds are inhibitors of tyrosine kinases, especially TIE-2, and Raf kinases, and can, inter alia, be used for the treatment of tumors.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAIiAzydPEHkb6eLp5-_n6uwQpu_kEKIR6uCiFBro4hvq5-IQr-bgrOjn7OrkEKLp7Bro7BrsE8DKxpiTnFqbxQmptBwc01xNlDN7UgPz61uCAxOTUvtSTeNcDQzMLI1MTC0dCYCCUAPAMoWg</recordid><startdate>20060726</startdate><enddate>20060726</enddate><creator>RAUTENBERG, WILFRIED</creator><creator>JONCZYK, ALFRED</creator><creator>SOLER RIERA, MARTA</creator><creator>MITJANS, FRANCESC</creator><creator>ROSELL-VIVES, ELISABET</creator><creator>ACKERMANN, KARL-AUGUST</creator><creator>ADAN, JAUME</creator><creator>HOELZEMANN, GUENTER</creator><creator>STAEHLE, WOLFGANG</creator><creator>CRASSIER, HELENE</creator><scope>EVB</scope></search><sort><creationdate>20060726</creationdate><title>PYRIDOPYRIMIDINONES FOR THE TREATMENT OF CANCER DISEASES</title><author>RAUTENBERG, WILFRIED ; JONCZYK, ALFRED ; SOLER RIERA, MARTA ; MITJANS, FRANCESC ; ROSELL-VIVES, ELISABET ; ACKERMANN, KARL-AUGUST ; ADAN, JAUME ; HOELZEMANN, GUENTER ; STAEHLE, WOLFGANG ; CRASSIER, HELENE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP1682548A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2006</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>RAUTENBERG, WILFRIED</creatorcontrib><creatorcontrib>JONCZYK, ALFRED</creatorcontrib><creatorcontrib>SOLER RIERA, MARTA</creatorcontrib><creatorcontrib>MITJANS, FRANCESC</creatorcontrib><creatorcontrib>ROSELL-VIVES, ELISABET</creatorcontrib><creatorcontrib>ACKERMANN, KARL-AUGUST</creatorcontrib><creatorcontrib>ADAN, JAUME</creatorcontrib><creatorcontrib>HOELZEMANN, GUENTER</creatorcontrib><creatorcontrib>STAEHLE, WOLFGANG</creatorcontrib><creatorcontrib>CRASSIER, HELENE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RAUTENBERG, WILFRIED</au><au>JONCZYK, ALFRED</au><au>SOLER RIERA, MARTA</au><au>MITJANS, FRANCESC</au><au>ROSELL-VIVES, ELISABET</au><au>ACKERMANN, KARL-AUGUST</au><au>ADAN, JAUME</au><au>HOELZEMANN, GUENTER</au><au>STAEHLE, WOLFGANG</au><au>CRASSIER, HELENE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRIDOPYRIMIDINONES FOR THE TREATMENT OF CANCER DISEASES</title><date>2006-07-26</date><risdate>2006</risdate><abstract>The invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X and X' have the designations cited in patent claim 1. Said compounds are inhibitors of tyrosine kinases, especially TIE-2, and Raf kinases, and can, inter alia, be used for the treatment of tumors.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP1682548A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | PYRIDOPYRIMIDINONES FOR THE TREATMENT OF CANCER DISEASES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T08%3A16%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RAUTENBERG,%20WILFRIED&rft.date=2006-07-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP1682548A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |